Publications

2020

Kalish JM, Tang X-, Scognamiglio T, Zhang T, Gudas LJ. Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma. Cancer Biol Ther. 2020;21(5):400-411.
Izzo F, Lee SC, Poran A, Chaligne R, Gaiti F, Gross B, et al. DNA methylation disruption reshapes the hematopoietic differentiation landscape. Nat Genet. 2020;52(4):378-387.
Chaekal O-, Scaradavou A, Frenet EM, Albano MS, Cushing M, Desai P, et al. Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response. Blood Adv. 2020;4(20):5146-5156.
Vickman RE, Faget DV, Beachy P, Beebe D, Bhowmick NA, Cukierman E, et al. Deconstructing tumor heterogeneity: the stromal perspective. Oncotarget. 2020;11(40):3621-3632.
Hernandez A, Schatz-Siemers N, Zhou F, Brandler TC, Negron R, Modi L, et al. Reporting of Benign Endometrial Cells in Papanicolaou Tests. Am J Clin Pathol. 2020;154(3):381-386.
Rubinstein MM, Goss C, Avecilla ST, Dubé GP, Riely GJ, Mones JV. Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness. Clin Case Rep. 2020;8(2):289-292.
Basourakos SP, Awamlh BA, Bianco FJ, Patel NA, Laviana A, Margolis DJ, et al. Feasibility of in-office MRI-targeted partial gland cryoablation for prostate cancer: an IDEAL stage 2A study. BMJ Surg Interv Health Technol. 2020;2(1):e000056.
Zhong E, Swistel A, Viswanathan K, Hoda SA. Leiomyoma of the Nipple: A common neoplasm in an uncommon location. Breast J. 2020;26(3):529-530.
Solomon JP, Arcila ME. Molecular Diagnostics of Non-Hodgkin Lymphoma. Cancer J. 2020;26(3):186-194.
Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, et al. Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas. Cancer Discov. 2020;10(7):964-979.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700